Moraru, Ioana G

Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study. [electronic resource] - Romanian journal of internal medicine = Revue roumaine de medecine interne - 143-7 p. digital

Publication Type: Comparative Study; Journal Article

1220-4749


Adult
Aged
Anti-Infective Agents--therapeutic use
Bacterial Infections--complications
Blind Loop Syndrome--drug therapy
Breath Tests--methods
Female
Hospitals, University
Humans
Intestine, Small--drug effects
Irritable Bowel Syndrome--drug therapy
Male
Middle Aged
Pilot Projects
Rifamycins--therapeutic use
Rifaximin
Treatment Outcome